SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020849
Filing Date
2023-05-11
Accepted
2023-05-11 07:38:07
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q caba-20230331.htm   iXBRL 10-Q 2509146
2 EX-10.1 caba-ex10_1.htm EX-10 253945
3 EX-31.1 caba-ex31_1.htm EX-31 22256
4 EX-31.2 caba-ex31_2.htm EX-31 22233
5 EX-32.1 caba-ex32_1.htm EX-32 13032
6 EX-32.2 caba-ex32_2.htm EX-32 13560
  Complete submission text file 0000950170-23-020849.txt   7929927

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT caba-20230331_pre.xml EX-101.PRE 258872
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT caba-20230331_lab.xml EX-101.LAB 356298
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT caba-20230331_def.xml EX-101.DEF 151007
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT caba-20230331.xsd EX-101.SCH 41015
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT caba-20230331_cal.xml EX-101.CAL 33878
51 EXTRACTED XBRL INSTANCE DOCUMENT caba-20230331_htm.xml XML 1294083
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 23908872
SIC: 2836 Biological Products, (No Diagnostic Substances)